CYTTA CORP.
A struggling OTC stock characterized by consistent annual net losses exceeding $4 million and total shareholder equity in deficit territory.
A struggling OTC stock characterized by consistent annual net losses exceeding $4 million and total shareholder equity in deficit territory.
A speculative investor might consider CYCA only for extreme turnaround potential or as a deep value play where the market has priced in total failure without accounting for hidden assets or restructuring opportunities. However, given the lack of revenue generation and massive accumulated deficits, any bullish case remains highly theoretical and unproven by current financial performance.
The stock should be avoided due to the fundamental business failure evidenced by three years of zero revenue and a consistent net loss trend worsening from -$5.1M to -$4.3M. Investors face an extremely high risk of permanent capital loss as the company burns through cash reserves while carrying significant debt obligations and no path to profitability visible in the data.
CYTTA CORP. (CYCA) is a financially distressed entity operating with negligible revenue and significant accumulated losses. The company reports minimal operational activity with no cost of revenue or substantial gross profit over the last three years, suggesting potential dormancy or severe business disruption.
Management has failed to turn around operations, resulting in a worsening cash flow from operations of -$1.8M and an operating profit deficit of -$3.9M driven by high general and administrative expenses. Despite non-cash adjustments and share-based compensation totaling over $4 million, the company continues to bleed cash with interest expenses consuming nearly 377k against no meaningful revenue.
The specific industry cannot be definitively identified due to the absence of cost of revenue and gross profit, which is atypical for active manufacturing or service sectors. This lack of standard operating metrics suggests the entity may have exited its primary market or operates in a highly niche sector where traditional financial reporting does not apply.
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $6.1K | $30.1K | $4.5K |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $6.1K | $30.1K | $4.5K |
| Operating Expenses | $5.1M | $4.7M | $3.9M |
| Operating Income | $1.6M | $-4.6M | $-3.9M |
| G&A | $1.1M | $1.8M | $871.1K |
| Stock-Based Comp | — | $3.1M | $2.0M |
| D&A | $47.6K | — | $624.5K |
| Depreciation | $47.6K | $45.4K | $41.4K |
| Other OpEx | $3.9M | $2.8M | $3.0M |
| Non-Operating Income | $-6.7M | $-107.0K | $-376.4K |
| Interest Expense | $48.8K | $107.2K | $377.0K |
| Interest Income | — | $150 | $522 |
| Pre-Tax Income | $-5.1M | $-4.7M | $-4.3M |
| Income Tax | $0 | $0 | $0 |
| Continuing Ops | $-5.1M | $-4.7M | $-4.3M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-5.1M | $-4.7M | $-4.3M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-5.1M | $-4.7M | $-4.3M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $788.0K | $1.7M | $2.0M |
| Accounts Receivable | $0 | — | — |
| Inventory | $0 | — | — |
| Other Current Assets | $788.0K | — | — |
| Long-Term Assets | $123.0K | $639.3K | $191.3K |
| PP&E (Net) | $123.0K | $77.6K | $50.9K |
| Other LT Assets | $0 | $561.8K | $140.4K |
| Total Assets | $911.0K | $2.3M | $2.2M |
| Current Liabilities | — | $2.6M | $2.4M |
| Other Current Liab | — | $2.5M | $2.4M |
| Long-Term Liabilities | — | $0 | $0 |
| Total Liabilities | $449.2K | $2.6M | $2.4M |
| Shareholders' Equity | $461.8K | $-260.4K | $-237.4K |
| Paid-In Capital | $28.0M | $31.9M | $36.2M |
| Retained Earnings | $-27.9M | $-32.6M | $-36.9M |
| Total L&E | $911.0K | $2.3M | $2.2M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-5.1M | $-4.7M | $-4.3M |
| Non-Cash Adjustments | $2.5M | $3.2M | $2.2M |
| Working Capital Changes | $218.5K | $52.4K | $236.8K |
| Cash from Operations | $-2.4M | $-1.4M | $-1.8M |
| Capital Expenditures | — | — | $14.7K |
| Cash from Investing | $0 | $0 | $-14.7K |
| Cash from Financing | $3.0M | $1.4M | $2.6M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $581.9K | $-80.3K | $765.0K |
| Beginning Cash | $173.2K | $755.1K | $674.8K |
| Ending Cash | $755.1K | $674.8K | $1.4M |
The financial data indicates a lack of traditional operating segments with zero cost of revenue and minimal gross profit, implying either a non-operational status, a holding company structure, or a business model that has failed to generate commercial traction recently.
1. Severe liquidity risk with current liabilities exceeding total assets and a significant retained earnings deficit of nearly $37 million. 2. High financial distress risk evidenced by consistent net losses and interest expenses outpacing revenue generation. 3. Existential business model risk as the company has generated zero revenue for three consecutive years, raising concerns about viability.
Due to the severe financial distress indicated by negative equity and losses, there are no sustainable competitive advantages; any potential moat is currently nonexistent as the company struggles with high interest expenses relative to its negligible earnings power.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.